Evolent Health (EVH) Profit After Tax (2014 - 2026)

Evolent Health has reported Profit After Tax for 13 years, with the latest figure at -$28.4 million in Q2 2026.

• On a quarterly basis, Profit After Tax rose 44.48% year-over-year to -$28.4 million in Q2 2026; TTM through Jun 2026 was -$512.1 million, a 176.51% decrease from a year earlier, with the FY2025 full-year figure at -$580.3 million, down 517.64% from the prior year.
• Profit After Tax was -$28.4 million for Q2 2026 at Evolent Health, down from -$27.6 million in the prior quarter.
• The five-year high for Profit After Tax was $2.1 million in Q3 2022, with the low at -$429.1 million in Q4 2025.
• Average Profit After Tax over 5 years is -$49.5 million, with a median of -$28.0 million recorded in 2026.
• The sharpest annual moves came in 2022 and 2023: Profit After Tax surged 116.28% in 2022, then tumbled 1663.64% in 2023.
• Over 5 years, Profit After Tax stood at -$11.3 million in 2022, then plunged by 264.75% to -$41.4 million in 2023, then gained by 26.04% to -$30.6 million in 2024, then slumped by 1301.7% to -$429.1 million in 2025, then surged by 93.39% to -$28.4 million in 2026.
• The last three Profit After Tax figures came in at -$28.4 million (Q2 2026), -$27.6 million (Q1 2026), and -$429.1 million (Q4 2025), per Business Quant data.